Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 8-19, January 2010

Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery☆☆

  • Jeysen Zivan Yogaratnam

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
    • Corresponding Author InformationCorresponding author. 2 Annandale Road, W4 2HF London, UK. Tel.: +44 7974214691.
  • ,
  • Gerard Laden

      Affiliations

    • North of England Hyperbaric and Medical Services, Classic Hospital, Lowfield Road, Anlaby, East Yorkshire, HU10 7AZ, United Kingdom
  • ,
  • Levant Guvendik

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
  • ,
  • Mike Cowen

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
  • ,
  • Alex Cale

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom
  • ,
  • Steve Griffin

      Affiliations

    • Department of Cardiothoracic Surgery, Castle Hill Hospital, Castle Road, HU16 JQ Cottingham, United Kingdom

Received 31 December 2008; received in revised form 16 March 2009; accepted 17 March 2009.

Abstract 

Objective

The objective of this study was to determine whether preconditioning coronary artery disease (CAD) patients with HBO2 prior to first-time elective on-pump cardiopulmonary bypass (CPB) coronary artery bypass graft surgery (CABG) leads to improved myocardial left ventricular stroke work (LVSW) post CABG. The primary end point of this study was to demonstrate that preconditioning CAD patients with HBO2 prior to on-pump CPB CABG leads to a statistically significant (P<.05) improvement in myocardial LVSW 24 h post CABG.

Methods

This randomised control study consisted of 81 (control group=40; HBO2 group=41) patients who had CABG using CPB. Only the HBO2 group received HBO2 preconditioning for two 30-min intervals separated 5 min apart. HBO2 treatment consisted of 100% oxygen at 2.4 ATA. Pulmonary artery catheters were used to obtain perioperative hemodynamic measurements. All routine perioperative clinical outcomes were recorded. Venous blood was taken pre HBO2, post HBO2 (HBO2 group only), and during the perioperative period for analysis of troponin T.

Results

Prior to CPB, the HBO2 group had significantly lower pulmonary vascular resistance (P=.03). Post CPB, the HBO2 group had increased stroke volume (P=.01) and LVSW (P=.005). Following CABG, there was a smaller rise in troponin T in HBO2 group suggesting that HBO2 preconditioning prior to CABG leads to less postoperative myocardial injury. Post CABG, patients in the HBO2 group had an 18% (P=.05) reduction in length of stay in the intensive care unit (ICU). Intraoperatively, the HBO2 group had a 57% reduction in intraoperative blood loss (P=.02). Postoperatively, the HBO2 group had a reduction in blood loss (11.6%), blood transfusion (34%), low cardiac output syndrome (10.4%), inotrope use (8%), atrial fibrillation (11%), pulmonary complications (12.7%), and wound infections (7.6%). Patients in the HBO2 group saved US$116.49 per ICU hour.

Conclusion

This study met its primary end point and demonstrated that preconditioning CAD patients with HBO2 prior to on-pump CPB CABG was capable of improving LVSW. Additionally, this study also showed that HBO2 preconditioning prior to CABG reduced myocardial injury, intraoperative blood loss, ICU length of stay, postoperative complications, and saved on cost, post CABG.

Keywords: Hyperbaric oxygen, Ischemic reperfusion injury, CABG

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Clinical Trial registration information: URL: http://clinicaltrials.gov/ct2/show/NCT00623142?term=hyperbaric+oxygen&rank=1.

☆☆ Unique identifier: NCT00623142.

 Funding source: Centre of Medical Excellence, Air Products Global Healthcare, Avda Tenerife 2, 28703 Madrid, Spain. Tel.: +34 629254357. Contact: Begoña Señor, M.D. Contact e-mail: senorccb@apci.com. Project Code Number: RD-06-0245.

PII: S1553-8389(09)00084-0

doi:10.1016/j.carrev.2009.03.004

Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 8-19, January 2010